{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:02:13Z","timestamp":1740142933850,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00508-019-1456-y","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T10:03:08Z","timestamp":1555063388000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gravidit\u00e4t bei vorbestehendem Diabetes (Update 2019)","Clinical practice recommendations for diabetes in pregnancy (Update 2019)"],"prefix":"10.1007","volume":"131","author":[{"given":"Alexandra","family":"Kautzky-Willer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Harreiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Winhofer-St\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimund","family":"Weitgasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Lechleitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"5","key":"1456_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2337\/dc08-9020","volume":"31","author":"JL Kitzmiller","year":"2008","unstructured":"Kitzmiller JL, Block JM, Brown FM, et\u00a0al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060\u201379. \n                    https:\/\/doi.org\/10.2337\/dc08-9020\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"9318","key":"1456_CR2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/s0140-6736(02)08599-9","volume":"359","author":"DS Feig","year":"2002","unstructured":"Feig DS, Palda VA. Type 2 diabetes in pregnancy: a\u00a0growing concern. Lancet. 2002;359(9318):1690\u20132. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(02)08599-9\n                    \n                  .","journal-title":"Lancet"},{"issue":"1\u20134","key":"1456_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11812-016-0078-9","volume":"11","author":"J Harreiter","year":"2016","unstructured":"Harreiter J, Kautzky-Willer A. Diabetes und Schwangerschaft. Wien Klin Wochenschr. 2016;11(1\u20134):23\u201342. \n                    https:\/\/doi.org\/10.1007\/s11812-016-0078-9\n                    \n                  .","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"1456_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/jwh.2010.2033","volume":"20","author":"A Handisurya","year":"2011","unstructured":"Handisurya A, Bancher-Todesca D, Schober E, et al. Risk factor profile and pregnancy outcome in women with type 1 and type 2 diabetes mellitus. J\u00a0Womens Health (Larchmt). 2011;20(2):263\u201371. \n                    https:\/\/doi.org\/10.1089\/jwh.2010.2033\n                    \n                  .","journal-title":"J Womens Health (Larchmt)"},{"issue":"Suppl 1","key":"1456_CR5","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.2337\/dc18-S013","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S137\u2013S43. \n                    https:\/\/doi.org\/10.2337\/dc18-S013\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"2","key":"1456_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2337\/dc16-1534","volume":"40","author":"SH O\u2019Brien","year":"2017","unstructured":"O\u2019Brien SH, Koch T, Vesely SK, et\u00a0al. Hormonal contraception and risk of thromboembolism in women with diabetes. Diabetes Care. 2017;40(2):233\u20138. \n                    https:\/\/doi.org\/10.2337\/dc16-1534\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"6","key":"1456_CR7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2337\/dc08-2061","volume":"32","author":"DM Jensen","year":"2009","unstructured":"Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009;32(6):1046\u20138. \n                    https:\/\/doi.org\/10.2337\/dc08-2061\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"4","key":"1456_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s00125-012-2455-y","volume":"55","author":"R Bell","year":"2012","unstructured":"Bell R, Glinianaia SV, Tennant PW, et al. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a\u00a0population-based cohort study. Diabetologia. 2012;55(4):936\u201347. \n                    https:\/\/doi.org\/10.1007\/s00125-012-2455-y\n                    \n                  .","journal-title":"Diabetologia"},{"key":"1456_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2393-6-30","volume":"6","author":"ME Inkster","year":"2006","unstructured":"Inkster ME, Fahey TP, Donnan PT, et\u00a0al. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth. 2006;6:30. \n                    https:\/\/doi.org\/10.1186\/1471-2393-6-30\n                    \n                  .","journal-title":"BMC Pregnancy Childbirth"},{"key":"1456_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005542.pub3","author":"D Farrar","year":"2016","unstructured":"Farrar D, Tuffnell DJ, West J, et\u00a0al. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev. 2016; \n                    https:\/\/doi.org\/10.1002\/14651858.CD005542.pub3\n                    \n                  .","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"1456_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00125-014-3163-6","volume":"57","author":"MM Kallas-Koeman","year":"2014","unstructured":"Kallas-Koeman MM, Kong JM, Klinke JA, et al. Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia. 2014;57(4):681\u20139. \n                    https:\/\/doi.org\/10.1007\/s00125-014-3163-6\n                    \n                  .","journal-title":"Diabetologia"},{"issue":"12","key":"1456_CR12","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2337\/dc18-1437","volume":"41","author":"DS Feig","year":"2018","unstructured":"Feig DS, Corcoy R, Donovan LE, et\u00a0al. Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care. 2018;41(12):2471\u20139. \n                    https:\/\/doi.org\/10.2337\/dc18-1437\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"10110","key":"1456_CR13","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, et\u00a0al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a\u00a0multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347\u201359. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(17)32400-5\n                    \n                  .","journal-title":"Lancet"},{"issue":"3","key":"1456_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/dia.2017.0386","volume":"20","author":"EM Scott","year":"2018","unstructured":"Scott EM, Bilous RW, Kautzky-Willer A. Accuracy, user acceptability, and safety evaluation for the freestyle libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther. 2018;20(3):180\u20138. \n                    https:\/\/doi.org\/10.1089\/dia.2017.0386\n                    \n                  .","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"1456_CR15","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1210\/jc.2013-2465","volume":"98","author":"I Blumer","year":"2013","unstructured":"Blumer I, Hadar E, Hadden DR, et\u00a0al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2013;98(11):4227\u201349. \n                    https:\/\/doi.org\/10.1210\/jc.2013-2465\n                    \n                  .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1456_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/thy.2016.0457","volume":"27","author":"EK Alexander","year":"2017","unstructured":"Alexander EK, Pearce EN, Brent GA, et\u00a0al. 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315\u201389. \n                    https:\/\/doi.org\/10.1089\/thy.2016.0457\n                    \n                  .","journal-title":"Thyroid"},{"issue":"5","key":"1456_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1464-5491.2012.03604.x","volume":"29","author":"L Ringholm","year":"2012","unstructured":"Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycaemia during pregnancy in women with Type 1 diabetes. Diabet Med. 2012;29(5):558\u201366. \n                    https:\/\/doi.org\/10.1111\/j.1464-5491.2012.03604.x\n                    \n                  .","journal-title":"Diabet Med"},{"issue":"9","key":"1456_CR18","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s00125-017-4351-y","volume":"60","author":"RS Lindsay","year":"2017","unstructured":"Lindsay RS, Loeken MR. Metformin use in pregnancy: promises and uncertainties. Diabetologia. 2017;60(9):1612\u20139. \n                    https:\/\/doi.org\/10.1007\/s00125-017-4351-y\n                    \n                  .","journal-title":"Diabetologia"},{"key":"1456_CR19","series-title":"NICE guideline (NG 3)","volume-title":"Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period","author":"National Institute for Health and Care Excellence","year":"2015","unstructured":"National Institute for Health and Care Excellence. Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE guideline (NG 3). 2015."},{"issue":"4","key":"1456_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2337\/dc06-1887","volume":"30","author":"ER Mathiesen","year":"2007","unstructured":"Mathiesen ER, Kinsley B, Amiel SA, et\u00a0al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a\u00a0randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care. 2007;30(4):771\u20136. \n                    https:\/\/doi.org\/10.2337\/dc06-1887\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"4","key":"1456_CR21","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.2337\/dc06-2586","volume":"30","author":"G Cianni Di","year":"2007","unstructured":"Di Cianni G, Volpe L, Ghio A, et\u00a0al. Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin. Diabetes Care. 2007;30(4):e11. \n                    https:\/\/doi.org\/10.2337\/dc06-2586\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"1","key":"1456_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.17925\/EE.2015.11.01.17","volume":"11","author":"Z Doder","year":"2015","unstructured":"Doder Z, Vanechanos D, Oster M, et al. Insulin Glulisine in pregnancy\u2014experience from clinical trials and post-marketing surveillance. Eur Endocrinol. 2015;11(1):17\u201320. \n                    https:\/\/doi.org\/10.17925\/EE.2015.11.01.17\n                    \n                  .","journal-title":"Eur. Endocrinol."},{"issue":"10","key":"1456_CR23","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2337\/dc11-2264","volume":"35","author":"ER Mathiesen","year":"2012","unstructured":"Mathiesen ER, Hod M, Ivanisevic M, et\u00a0al. Maternal efficacy and safety outcomes in a\u00a0randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012;35(10):2012\u20137. \n                    https:\/\/doi.org\/10.2337\/dc11-2264\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"6","key":"1456_CR24","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/dmrr.1213","volume":"27","author":"ER Mathiesen","year":"2011","unstructured":"Mathiesen ER, Damm P, Jovanovic L, et\u00a0al. Basal insulin analogues in diabetic pregnancy: a\u00a0literature review and baseline results of a\u00a0randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev. 2011;27(6):543\u201351. \n                    https:\/\/doi.org\/10.1002\/dmrr.1213\n                    \n                  .","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1456_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/14767058.2013.799650","volume":"27","author":"M Hod","year":"2014","unstructured":"Hod M, Mathiesen ER, Jovanovic L, et\u00a0al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J\u00a0Matern Fetal Neonatal Med. 2014;27(1):7\u201313. \n                    https:\/\/doi.org\/10.3109\/14767058.2013.799650\n                    \n                  .","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"1456_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00404-015-3692-3","volume":"292","author":"S Lv","year":"2015","unstructured":"Lv S, Wang J, Xu Y. Safety of insulin analogs during pregnancy: a\u00a0meta-analysis. Arch Gynecol Obstet. 2015;292(4):749\u201356. \n                    https:\/\/doi.org\/10.1007\/s00404-015-3692-3\n                    \n                  .","journal-title":"Arch Gynecol Obstet"},{"key":"1456_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12721","author":"A Milluzzo","year":"2017","unstructured":"Milluzzo A, Tumminia A, Scalisi NM, et\u00a0al. Insulin degludec in the first trimester of pregnancy: report of two cases. J\u00a0Diabetes Investig. 2017; \n                    https:\/\/doi.org\/10.1111\/jdi.12721\n                    \n                  .","journal-title":"J Diabetes Investig"},{"issue":"8","key":"1456_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11892-016-0765-z","volume":"16","author":"AZ Feldman","year":"2016","unstructured":"Feldman AZ, Brown FM. Management of type 1 diabetes in pregnancy. Curr Diab Rep. 2016;16(8):76. \n                    https:\/\/doi.org\/10.1007\/s11892-016-0765-z\n                    \n                  .","journal-title":"Curr Diab Rep"},{"key":"1456_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4587064","volume":"2018","author":"J\u00fcrgen Harreiter","year":"2018","unstructured":"Harreiter J, Schindler K, Bancher-Todesca D, et al. Management of pregnant women after Bariatric surgery. J\u00a0Obes. 2018; 4587064. \n                    https:\/\/doi.org\/10.1155\/2018\/4587064\n                    \n                  .","journal-title":"Journal of Obesity"},{"key":"1456_CR30","volume-title":"Embryotox \u2013 Arzneimittelsicherheit in Schwangerschaft und Stillzeit","author":"Pharmakovigilanz- und Beratungszentrum f\u00fcr Embryonaltoxikologie","year":"2018","unstructured":"Pharmakovigilanz- und Beratungszentrum f\u00fcr Embryonaltoxikologie, Institut f\u00fcr Klinische Pharmakologie und Toxikologie, Charit\u00e9. Embryotox \u2013 Arzneimittelsicherheit in Schwangerschaft und Stillzeit. 2018. \n                    https:\/\/www.embryotox.de\n                    \n                  . Zugegriffen: 7. Apr. 2018."}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-1456-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-019-1456-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-1456-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:21:33Z","timestamp":1586560893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-019-1456-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":30,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1007\/s00508-019-1456-y","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"type":"print","value":"0043-5325"},{"type":"electronic","value":"1613-7671"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"12 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Kautzky-Willer hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen\/Honorare erhalten: Eli Lilly, Novo Nordisk, Sanofi-Aventis. J.\u00a0Harreiter hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen\/Honorare erhalten: Astra Zeneca, Novo Nordisk, Takeda. Y.\u00a0Winhofer-St\u00f6ckl hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen\/Honorare erhalten: Sanofi Aventis, Eli Lilly, Astra Zeneca, Novartis. R.\u00a0Weitgasser hat von folgenden Unternehmen, die teils auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Abbott, Allergan, Astra Zeneca, Boehringer-Ingelheim, Dexcom, Eli Lilly, MSD, Novo Nordisk, Roche, Sanofi, Servier, Takeda. M.\u00a0Lechleitner hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Honorare erhalten: Astra Zeneca, Bristol-Myers Squibb, Germania Pharmazeutika, GlaxoSmithKline Pharma, Eli Lilly, Medtronic, Merck Sharp&Dome, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Takeda.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}